Policy continuity needed to speed up orphan drugs process, says biopharmaceutical group
Brussels, 20 Jun 2003 While the procedure for 'designating' drugs for orphan diseases has improved dramatically in the EU, further ground must be made to get orphan drugs out of the laboratory and...